12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaJan 16 16:05 ET

We're Hopeful That ArriVent BioPharma (NASDAQ:AVBP) Will Use Its Cash Wisely

Simply Wall StJan 11 07:01 ET

ArriVent BioPharma Advances Cancer Therapeutics Pipeline

TipRanksNov 18, 2024 23:03 ET

H.C. Wainwright Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsNov 15, 2024 06:34 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on ArriVent BioPharma, Maintains $36 Price Target

BenzingaNov 15, 2024 06:26 ET

ArriVent BioPharma, Inc.: Promising Clinical Trials and Strategic Collaborations Drive Buy Rating

TipRanksNov 15, 2024 06:05 ET · Ratings